Out-patient management of bronchial asthma.
Asthma, seen primarily as an inflammatory disease with secondary airway hyper-responsiveness, causes symptoms through contraction of the airway's smooth muscles. The management of chronic asthma relies on bronchodilators for symptomatic relief of bronchospasm, while primary therapy is used to either prevent or reverse the inflammatory component of the disease. Anti-inflammatory therapeutic strategies include environmental control (where relevant), sodium cromoglycate (where appropriate), and both inhaled and oral glucocorticosteroids. Management of acute severe asthma is similar; bronchodilators are used to "buy time" while systemic corticosteroids control the inflammatory process.
D W
DW
Cockcroft
Eur J Respir Dis Suppl. 1986;147:223-6
2429855
J Allergy Clin Immunol. 1988 Jan;81(1):83-8
3123538
J Allergy Clin Immunol. 1988 Dec;82(6):957-60
3060512
J Allergy Clin Immunol. 1987 May;79(5):734-40
3106449
J Allergy Clin Immunol. 1988 Jan;81(1):111-9
3276756
Ann Allergy. 1987 Dec;59(6):405-14
3122604
Am Rev Respir Dis. 1987 Aug;136(2):379-83
3304046
Chest. 1988 Oct;94(4):675-6
3168561
Chest. 1982 Jul;82(1 Suppl):30S-32S
6806019
Chest. 1986 Oct;90(4):575-7
3019612
J Allergy Clin Immunol. 1979 Jan;63(1):28-34
758339
Lancet. 1982 Sep 25;2(8300):675-8
6126624
J Allergy Clin Immunol. 1987 Apr;79(4):653-9
3549842
J Allergy Clin Immunol. 1985 Apr;75(4):460-7
3920301